Brief: Northwest Biotherapeutics enters letter agreement with Cognate Bioservices
19/10/2016 22:32
Oct 19 (Reuters) - Northwest Biotherapeutics Inc NWBO.O
* Entered letter agreement with Cognate Bioservices relating
to institutional financing of Cognate
* Says agreement also reaffirms that nothing in it overrides
August 28, 2016 exchange agreement- SEC filing
Source text for Eikon: ID:nEOL418VXh
Further company coverage: NWBO.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB